
Hepatoma Research
@hepatomares
A gold open-access journal, indexed in ESCI and Scopus, 2023 IF: 1.7. #livercancer #HCC #CCA #Hepatitis #liverdisease #livertwitter #MedEd #HCCtwitter
ID: 2992903758
https://www.oaepublish.com/hr 23-01-2015 05:44:02
7,7K Tweet
2,2K Followers
4,4K Following

👂We’ve noticed your interest in Exploring Combined Treatments for #HCC 。 Please leave your valuable feedback.🖌️ Suman Verma Hepatology HGTiP Mark B. Pochapin, MD Hugh Thomas Parimita Barua, DM Hepatology St George's Hospital Hepatology

🙋We have noticed your interest in #ChronicLiverDisease and #HCC Surveillance Feel free to share your insights and join the discussion!🩷 Sanjaya Satapathy Debbie Shawcross Keith Siau TheLiverDoc Carl Kay, MD Amith John Damianos, M.D.


✨ Newly published review "HCC in MASLD: radiological appearance, diagnosis and treatment‘ by Dr. Marco Dioguardi Burgio’s team! Maxime Ronot Federica Vernuccio Roberto Cannella Marco Dioguardi Burgio 🔗 Full Paper: oaepublish.com/articles/2394-… #HCC #MASLD #livertwitter #MedEd



📢 Highly recommended commentary from Prof. Ju Dong Yang's team on "#Ethnic #disparities in the #epidemiology, #treatment, and #outcome of patients with hepatocellular carcinoma in the United States" 📖 Welcome to read more: oaepublish.com/articles/2394-… #livertwitter #meded #HCC


It reveals critical differences in HCC care & survival across ethnic groups. A must-read for all working on health equity! Thanks for sharing! Fasiha Kanwal Rodrigo Alterio, MD Ruben Hernaez Yamini Natarajan, MD Andrew Moon Nicole Rich Amit G Singal Cecilia Monge B, MD Dataemia Neena S Abraham MD MACG FASGE AGAF



📢Top pick: Review by Prof. Ludovico Abenavoli's team on #NAFLD to #MASLD transition. "#Dysmetabolic #Comorbidities and Non-Alcoholic Fatty Liver Disease: A Stairway to Metabolic Dysfunction-Associated Steatotic Liver Disease" 📖 More:oaepublish.com/articles/2394-… #livertwitter #meded


Delivers a comprehensive look at NAFLD → MASLD in the context of metabolic dysfunction !Appreciate your insights! 👏 Nahum Méndez-Sánchez EMIDIO SCARPELLINI UNAM Clemson University Juan Pablo (JP) Arab, MD MASLD Research Center Dr.V.Mohan Health Tech World Jeffrey V. Lazarus Scott Isaacs


The synergy between local and systemic therapies is showing exciting potential to improve survival rates and reduce recurrence in HCC patients. Ezequiel Ridruejo MD FAASLD PhD Thomas Dayspring Flavio G Rocha, MD, FACS, FSSO Mukul Vij, MD 🇮🇳 Arndt Vogel Adam L. Booth, MD Erman Akkus Tim Brown, MD MSCE Federico Rossari


The Mediterranean diet shows promise as a safe, natural, and effective approach for preventing the progression of NAFLD to NASH. 🔹 Appreciate the great work and contribution from Prof. Ludovico Abenavoli’s team! Univ of Florida University of Florida News Michael Weintraub, MD Dr Alo, DO, FACC Jonathan G. Stine, MD MSc, FACP



📢 Editor’s Recommendation Prof Allan Tsung and Leva Gorji’s team exploring barriers to hepatocellular cancer surveillance in chronic liver disease patients from providers' perspectives. #HCC #cirrhosis #chronic liver disease #Cancer Screening 👉 Click oaepublish.com/articles/2394-…


🔎It Highlights provider, patient & system-level barriers to HCC screeningt. A step toward improving early detection & health equity in liver care. Eliza W. Beal Peter Sasieni Lorraine Stiehl Ezequiel Ridruejo MD FAASLD PhD Rashid Lui 雷諾信 Brett E Fortune MD Fady M. Kaldas, MD Łukasz Masior Lorraine Stiehl